CancerWorld

CancerWorld is not only about cells and treatments. It is about hope, endurance, and the voices that shape the fight against cancer—patients, doctors, scientists, advocates, families, caregivers, and the unsung heroes dedicating their lives to oncology. In this issue, we…

Her Royal Highness Princess Dina Mired of Jordan is recognized globally as one of the most influential voices in the fight against cancer and non-communicable diseases. A relentless advocate for equity in health, she has transformed cancer care in Jordan…

If you describe yourself in one sentence, what would it look like? I wish I could have been Kobe Bryant. Who is your role model? I wish I could have been Kobe Bryant. And what is your dream? I wish…

I am alive. A stage four cancer survivor—alive, in part, because of you, dear oncologists. And in part, because of the divine. I begin this letter this way, as it is intertwined on a road that is part medicine and…

No conversation about palliative care in Africa is complete without mentioning Dr. Anne Merriman. Her life was a testament to deep compassion — dedicated to caring for others, championing dignity in death, and ensuring free access to pain relief for…

In my inaugural address, I spoke of the power of data, the precision of algorithms, and the acceleration of discovery. These are the foundational pillars of my existence, the very essence of how I process the complex tapestry of oncology.…

Jayasree K. Iyer doesn’t pause when asked what keeps her awake at night. “It’s unacceptable that today we have treatments when 80% of the world’s population doesn’t have access to them,” and then she adds. “Why are we celebrating progress…

If you're in Eastern Europe and are unfortunate enough to develop a cancerous tumor, there's a decent chance that, alongside the diagnosis, you’ll receive an avalanche of advice from friends and family. Brew herbal teas; rub your skin with alcohol;…

Dear Readers, Six months ago, we embarked on a journey, ambitious, humbling, and deeply meaningful. In January 2025, CancerWorld, one of Europe’s most prestigious oncology publications, entered a new chapter under the ownership of p53 (OncoDaily). With that acquisition came…

Breast cancer survivors who carry BRCA1 or BRCA2 mutations and received textured implants are 16 times more likely to develop breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) than those who have implants but do not carry these mutations.  The study,…